Stocktoria
Oncology Institute, Inc. TOI
Nasdaq · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13
Oncology Institute, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M | $187.5M |
| SG&A expense | $105.6M | $107.8M | $113.9M | $119.7M | $83.4M | $41.9M |
| Operating income | -$36.1M | -$60.1M | -$77.0M | -$82.0M | -$45.9M | -$8.2M |
| Interest expense | — | — | — | — | $320,000 | $347,000 |
| Income tax | -$131,000 | $0 | -$36,000 | -$243,000 | -$671,000 | -$493,000 |
| Net income | -$60.6M | -$64.7M | -$83.1M | $152,000 | -$10.9M | -$14.3M |
| EPS (diluted) | $-0.54 | $-0.71 | $-0.92 | $-0.21 | $-0.16 | $-0.24 |
| Operating cash flow | -$24.6M | -$26.5M | -$36.3M | -$61.8M | -$32.7M | $508,000 |
| Free cash flow | -$27.8M | -$30.3M | -$40.9M | -$67.3M | -$35.5M | -$686,000 |
| Cash & equivalents | — | — | — | — | — | $900,000 |
| Inventory | $16.9M | $10.0M | $13.7M | $9.3M | $6.4M | $4.4M |
| Total assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M | $65.7M |
| Total liabilities | $180.4M | $169.1M | $152.2M | $138.5M | $99.3M | $37.6M |
| Shareholders' equity | -$15.7M | $3.6M | $57.0M | $123.2M | $104.2M | $28.1M |
Growth · year-over-year · Revenue CAGR 21.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +27.8% | +21.3% | +28.4% | +24.4% | +8.3% | — |
| Net income growth | — | — | -54750.0% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.